Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DX25F6ADA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $48,463
Award facts
- Contract value 100% obligated
- $48,462.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $48.46K for 60 tablets of Jakafi 10 mg, a medication used to treat myelofibrosis and polycythemia vera. The award was issued on August 12, 2025, with an ultimate completion date of August 13, 2025, under a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $500 million through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide.
The contract is funded through the Medical Supply Chain division of the Defense agency, with place of performance at the company's Park Ridge, Illinois location. As a registered federal contractor since 2001, DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription medications, biologics, and medical consumables to military health facilities. This particular delivery order represents one of numerous firm fixed-price task orders issued under the company's larger DLA pharmaceutical supply agreement, supporting the ongoing medical supply requirements of Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DX25F6ADA?
SPE2DX25F6ADA was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 12, 2025.
How much is contract SPE2DX25F6ADA worth?
The government has obligated $48,463 on SPE2DX25F6ADA.
Is contract SPE2DX25F6ADA an order under another contract?
Yes. SPE2DX25F6ADA is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ADA competed?
The extent of competition for SPE2DX25F6ADA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award